Blog
Quietly, CV Sciences Is Succeeding in a Competitive CBD Market
For years, marijuana stocks could do no wrong. All cannabis companies simply had to do was promise investors pie-in-the-sky growth over the long run, and their share prices shot into the heavens.
Why a $399 iPhone Could Give Apple's Sales a Big Boost Next Year
Owning an Apple (NASDAQ: AAPL) device can be an expensive proposition for users who want to keep up with the latest and greatest model. Shelling out potentially $1,000+ every year just to stay
Who Gets a Special Enrollment Period for Medicare Part B?
Once you leave the workforce and enter retirement, Medicare is what you'll rely on for healthcare coverage. Medicare eligibility kicks in at age 65, and your initial window to sign up begins three
Netflix Bounced Back, but It's Next Quarter That Matters More
Netflix (NASDAQ: NFLX) had a rough Q2. Its U.S. subscriber base shrank for the first time in eight years, and international growth was not enough to save the company from missing growth projections
3 Top Energy Stocks to Buy Right Now
The energy sector can be a confusing and difficult arena for investment. That's why it's important to choose companies that communicate openly to their shareholders and display a balance of prudence
Trade War Fallout: Texas Instruments Earnings, Sales, and Guidance Plunge in Q3
Semiconductor giant Texas Instruments (NASDAQ: TXN) reported third-quarter results after the closing bell on Tuesday. Earnings looked good at first glance, but revenues came in below Wall Street's
Will a $48 Billion Global Settlement End U.S. Opioid Crisis Lawsuits?
The opioid epidemic is a complex problem with no simple or ideal solution. The Centers for Disease Control and Prevention (CDC) estimates that 47,600 Americans died from opioid-related overdoses in
How Risky Is Care.com?
On the surface, Care.com (NYSE: CRCM) appears to be a sound investment. The company is the world's largest online platform for connecting families with at-home care providers such as childcare
AssetMark Financial Goes Public in Growing TAMP Market
AssetMark Financial (NYSE: AMK), which went public in July, is emerging as a major player in turnkey asset management programs, or TAMPs. A TAMP is a platform that allows financial advisors
Better Buy: Aphria vs. Constellation Brands
Some great news could be on the way for Aphria (NYSE: APHA) and Constellation Brands (NYSE: STZ). Both companies stand to win as the Canadian cannabis derivatives products hit the shelves in
The 5 Biggest Concerns for U.S. Pot Stocks
Although it may not seem like it at the moment, with cannabis stocks going up in smoke of late, legal marijuana offers some of the brightest growth prospects of any industry over the next decade
Taco Bell's Beef Recall Could Be More Serious Than "Tortillapocalypse"
Taco Bell recalled 2.3 million pounds of beef from restaurants in 21 states because metal filings were found by a customer, and though the Yum! Brands (NYSE: YUM) Mexican food chain seems to have
Earnings: 3 Tech Stocks to Watch This Week
As earnings season continues, a number of tech companies are coming into focus this week. Three worth watching are digital payments company PayPal (NASDAQ: PYPL), software giant Microsoft (NASDAQ:
The Greatest Dividend Stock That You've Never Heard Of
More often than not, dividends form the financial foundation of any successful long-term investment portfolio. Aside from the fact that dividend-paying stocks have historically run circles around
Should Boston Beer Investors Worry That It Just Changed the Taste of Its Hard Seltzer?
In a bid to keep the Summer of Seltzer bubbling along well into the future, Boston Beer (NYSE: SAM) announced it has reformulated the entire lineup of its Truly brand of hard seltzer to give it a
Is AMC Entertainment a Buy After Announcing Video Streaming Plans?
2019 has been billed as a transitional year by AMC Entertainment's (NYSE: AMC) management. It's the year that Stubs A-List -- the company's subscription service answer to the now-defunct MoviePass
Here's Why Biogen's Big Gain Won't Last Long
Millions of Alzheimer's disease patients, their families, and their friends felt their hearts sink when Biogen (NASDAQ: BIIB) broke the bad news that an experimental Alzheimer's therapy, aducanumab
7 Money-Saving Tips That Actually Work
iLet's be honest: Saving money isn't much fun. But If we spent it all without care, we'd never reach long-term goals like buying a home or retiring. Like it or not, unless you win the lottery or
Is Biogen a Buy After the Biggest Biotech Bombshell in Years?
Biogen (NASDAQ: BIIB) has been a bust for much of 2019. The stock plunged in March after the company halted two late-stage clinical studies evaluating aducanumab in treating Alzheimer's disease. But
Is GW Pharmaceuticals an Opportunity Before Earnings?
GW Pharmaceuticals (NASDAQ: GWPH), a U.K.-based company, is a biotech that has pioneered the medical cannabis field and is capitalizing on its first-mover advantage.
Founded in 1998, biotech
Why Hasn't Record Low Unemployment Led to Higher Wages?
When it comes to the U.S. workforce, the "law" of supply and demand just isn't getting the job done. One might expect that with unemployment at a 50-year low, companies would be paying more to
Better Buy: NVIDIA vs. Qualcomm
It's been a volatile year for both NVIDIA (NASDAQ: NVDA) and Qualcomm (NASDAQ: QCOM). Both companies have faced challenges, and yet they've still been performing very well so far in 2019, with
Manhattan Associates (MANH) Q3 2019 Earnings Call Transcript
Image source: The Motley Fool.
Manhattan Associates (NASDAQ: MANH)Q3 2019 Earnings CallOct 22, 2019, 4:30 p.m. ET
Operator
Source Fool.com
Veracyte (VCYT) Q3 2019 Earnings Call Transcript
Image source: The Motley Fool.
Veracyte (NASDAQ: VCYT)Q3 2019 Earnings CallOct 22, 2019, 5:00 p.m. ET
Operator
Source Fool.com
Southern Missouri Bancorp Inc (SMBC) Q1 2020 Earnings Call Transcript
Image source: The Motley Fool.
Southern Missouri Bancorp Inc (NASDAQ: SMBC)Q1 2020 Earnings CallOct 22, 2019, 4:30 p.m. ET
Operator
Source Fool.com